Valuation study

We are pleased to announce that data collection for the new UK EQ-5D-5L valuation study was completed on September 18, 2023. For this study, 1200 subjects were recruited in the UK, who were interviewed by videoconference or face-to-face. On November 14, 2023 a Steering Group meeting took place where reports on the complete data set…

After successfully completing a pilot phase of interviewer training and data collection at the end of 2022, we are pleased to announce that the first participant in the new UK EQ-5D-5L valuation study was interviewed on 29 January 2023. Interviewer data will be collected online and face-to-face, to allow as many people to participate as…

The research team for the UK EQ-5D-5L valuation study has been updated. The lead investigator is Donna Rowen (School of Health and Related Research, University of Sheffield) and co-investigators are: This team has been carefully selected by the project’s Steering Group and will bring significant experience and expertise to the valuation study.

In line with the study governance document, the Steering Group has appointed the following four scientists as members of the Quality Control (QC) team: The QC team will be independent from the study team, EuroQol’s EQ-VT support team and the Steering Group. This team is responsible for reviewing and critically assessing the work of the…

Following the emergence of the COVID-19 pandemic, the Steering Group discussed the feasibility of undertaking the EQ-5D-5L valuation study for the United Kingdom during the COVID-19 pandemic. The question was whether the EQ-VTv2 TTO interviews could be conducted remotely using online videoconferencing software (such as Zoom or Microsoft Teams), and whether the results would be…

We are delighted to announce the start date of the new EQ-5D-5L valuation study for the United Kingdom. The study proposal and statistical analysis plan were approved for funding by EuroQol’s Executive Committee in June and have also now been signed off by the study’s Steering Group. The study team aim to start sample recruitment…

The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s Steering Group and come from across the United Kingdom, thereby helping to ensure regional coverage for the study. Donna Rowen…

Several expressions of interest were received for joining the Steering Group of the new UK EQ-5D-5L valuation study. At their meeting of 11MAR2020 the initial members of the Steering Group decided to appoint three academic experts to join the Steering Group: The Steering Group now consists of nine members. Listed below you find the other…

Several expressions of interest were received for joining the Steering Group of the new UK EQ-5D-5L valuation study. At their meeting of 11MAR2020 the initial members of the Steering Group decided to appoint three academic experts to join the Steering Group: The Steering Group now consists of nine members. Listed below you find the other…

February 12, 2020 On 24 October 2019 EuroQol and NICE announced that a new EQ-5D-5L valuation study will be undertaken in the UK, following NICE’s decision not to use the EQ-5D-5L value set for England (Devlin et al 2018). This new study will be funded and managed by EuroQol. NICE, the Department of Health and…